NASDAQ:TRVN Trevena Q1 2024 Earnings Results & Report $0.07 0.00 (0.00%) As of 10/12/2026 02:57 PM Eastern Trevena beat analyst earnings expectations in its Q1 2024 results, released May 15, 2024. The company reported EPS of -$9.00 versus the -$9.25 consensus estimate, while revenue was $0.02 million. Research:Profile Earnings Announcement Details QuarterQ1 2024Report DateMay 15, 2024 Trevena EPS ResultsActual EPS-$9.00Consensus EPS -$9.25Beat/MissBeat by +$0.25One Year Ago EPSN/AEPS Beat Rate6 of last 8 quartersTrevena Revenue ResultsActual Revenue$0.02 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsTrevena's next earnings date is estimated for Thursday, November 5, 2026, based on past reporting schedules. Conference Call ResourcesCompany Profile Trevena Q1 2024 Earnings FAQ Did Trevena beat earnings estimates for Q1 2024? Trevena (NASDAQ:TRVN) reported earnings of -$9.00 per share for Q1 2024, beating the consensus estimate of -$9.25. The report was announced on Wednesday, May 15, 2024. What was Trevena's revenue for Q1 2024? Trevena reported revenue of $0.02 million for Q1 2024. When is Trevena's next earnings date? Trevena's next earnings date is estimated for Thursday, November 5, 2026. MarketBeat tracks confirmed and estimated earnings dates for Trevena on the company's earnings history page. Trevena Earnings HeadlinesTrevena (NASDAQ:TRVN) Share Price Crosses Above Fifty Day Moving Average - Should You Sell?October 6, 2026 | americanbankingnews.comTrevena Inc.May 27, 2026 | marketwatch.comBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going to hell." Ray Dalio agrees. The founder of Bridgewater Associates ($150 billion AUM) calls it a "debt death spiral." But there's a specific asset class and investment system that actually thrives when the dollar collapses.October 13 at 1:00 AM | Decentralized Masters (Ad)Trevena Restructures China Royalty Rights to Exit DebtJanuary 14, 2026 | tipranks.comSoftball: Conrad Weiser’s Alex Trevena earns statewide player of the year award; 5 other Berks players honoredJuly 8, 2025 | msn.comTrevena, Inc. (TRVN) - Yahoo FinanceJune 29, 2025 | finance.yahoo.comSee More Trevena Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Trevena? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Trevena and other key companies, straight to your email. Email Address About TrevenaTrevena (NASDAQ:TRVN) is a biopharmaceutical company focused on developing medicines for central nervous system disorders, with an emphasis on addressing the limitations of existing opioid and other neurological therapies. The company was founded in 2007 and is headquartered in Chesterbrook, Pennsylvania. Trevena’s principal commercial product is OLINVYK (oliceridine) injection, an intravenous opioid approved by the U.S. Food and Drug Administration for the management of acute pain in adults severe enough to require an intravenous opioid analgesic. OLINVYK was designed to provide pain relief while potentially reducing certain adverse effects associated with conventional opioids, although it carries the risks and precautions associated with opioid medicines. The company has also researched additional compounds for neurological conditions, including investigational therapies intended for disorders such as pain and epilepsy. Trevena’s commercial activities have primarily focused on the United States, while its development and licensing efforts have included relationships intended to support access to international markets. Information about the company’s current leadership and operating status may change over time.View Trevena ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow RunwayJPMorgan Earnings Miss Estimates But Reveal Broad-Based StrengthAmazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?A Silent Winner: Texas Instruments Anchors the AI SupercycleDelta's Guidance Cut Could Spell Trouble for the Airline Industry5 Retail Picks to Watch as the Holiday Shopping Season Nears Upcoming Earnings Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026)Fastenal (10/14/2026)ASML (10/14/2026)Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
